This post by @cdibb is so on the money I couldn’t have worded it better myself.
The positive spin on this announcement by many on the forum this morning has been nauseating.
And @Mr_Cod I usually like your posts but to suggest that the end points have already been agreed with the FDA, but both parties will have a meeting about it in April to discuss the endpoints is frankly ludicrous. Perhaps you didn’t read the announcement carefully enough.
This announcement should have been price sensitive IMO (to the downside) whereas why was the receiving funds from the PRV sale price sensitive? The market knew about the sale and imminent receipt of funds.
And while I’m at it, I don’t like hype spin from companies, but would it hurt Neuren to sell some sizzle and put more effort into positive announcements? The PRV sale proceeeds could have specified exactly how much they received after costs, how much is now in the bank and why the company is in great shape to execute plans Z,Y,Z. I’m a bit over these vanilla worded announcements. It’s our public company!
Rant over. I’m still bullish on NEU. Have a great day.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)